By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The stocks of many players in the genomics tools field rose yesterday following Roche's $5.7 billion hostile takeover bid for Illumina.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.
A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.
As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.
The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.